Estados financieros detallados de Insight Molecular Diagnostics Inc. (IMDX): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Insight Molecular Diagnostics Inc. registró ingresos de $4.1M en el último ejercicio fiscal, con un CAGR de 5 años del 27.2%.
Márgenes de los últimos 12 meses: margen bruto 11.2%, margen operativo -25.6%, margen neto -29.6%.
Al precio actual de $3.58, IMDX presenta beneficios negativos (P/E no significativo) y un ROE del 271.76%. La capitalización bursátil es de $116M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | 0 | $1.2M | $2.2M | $958000 | $1.5M | $1.9M | $4.1M |
| Coste de Ventas | $387000 | $580000 | $559000 | $344000 | $1.9M | $778000 | $976000 | $1.1M | $1.1M | $3.9M |
| Beneficio Bruto | -$387000 | -$580000 | -$559000 | -$344000 | -$639000 | $1.4M | -$18000 | $413000 | $740000 | $190000 |
| I+D | $5.7M | $7.2M | $6.5M | $6.8M | $9.8M | $5.0M | $7.3M | $9.3M | $9.8M | $15.9M |
| Generales y Administrativos | $5.5M | $11.7M | $8.7M | $15.4M | $23.3M | $20.4M | $21.5M | $13.3M | $13.8M | $17.0M |
| Gastos Operativos | $11.1M | $18.8M | $15.2M | $22.2M | $29.1M | $55.1M | $18.0M | $25.5M | $61.8M | $30.8M |
| Beneficio Operativo | -$11.1M | -$18.8M | -$15.2M | -$22.2M | -$29.7M | -$53.7M | -$18.0M | -$25.1M | -$61.0M | -$30.6M |
| EBITDA | -$11.1M | -$18.3M | -$15.2M | -$21.9M | -$30.5M | -$48.5M | -$13.3M | -$23.1M | -$59.0M | -$47.9M |
| Gastos por Intereses | $28000 | $217000 | $216000 | $299000 | $252000 | $209000 | $83000 | $52000 | $84000 | $109000 |
| Beneficio Antes de Impuestos | -$11.2M | -$19.4M | -$15.8M | -$22.4M | -$31.2M | -$52.9M | -$18.6M | -$24.9M | -$60.7M | -$50.2M |
| Impuestos | 0 | 0 | 0 | 0 | -$1.3M | -$9.3M | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$11.2M | -$19.4M | -$15.8M | -$22.3M | -$29.9M | -$64.1M | -$72.9M | -$27.8M | -$60.7M | -$50.2M |
| BPA | $-8.42 | $-12.83 | $-8.32 | $-8.71 | $-9.14 | $-14.40 | $-20.00 | $-3.75 | $-4.66 | $-1.65 |
| BPA Diluido | $-8.42 | $-12.83 | $-8.32 | $-8.71 | $-9.14 | $-14.40 | $-20.00 | $-3.75 | $-4.66 | $-1.65 |
| Acciones en Circulación (Diluidas) | $1.3M | $1.5M | $1.9M | $2.6M | $3.3M | $4.4M | $5.5M | $7.7M | $13.1M | $30.5M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $260000 | $1.1M | $32000 | $239000 |
| Beneficio Bruto | $139000 | $496000 | -$605500 | $157000 |
| Beneficio Operativo | -$11.0M | -$9.9M | -$10.3M | -$11.4M |
| EBITDA | -$10.2M | -$22.4M | -$3.6M | -$10.6M |
| Beneficio Neto | -$10.9M | -$23.0M | -$4.3M | -$11.3M |
| BPA | $-0.34 | $-0.75 | $-0.12 | $-0.31 |
| BPA Diluido | $-0.34 | $-0.75 | $-0.12 | $-0.31 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $10.2M | $7.6M | $8.0M | $22.1M | $7.1M | $32.9M | $20.0M | $9.4M | $8.6M | $11.6M |
| Inversiones a Corto | $2.2M | $760000 | $428000 | $379000 | $675000 | $904000 | $433000 | 0 | 0 | 0 |
| Cuentas por Cobrar | 0 | 0 | 0 | 0 | $203000 | $1.4M | $2.0M | $484000 | $1.6M | $1.1M |
| Inventario | 0 | 0 | 0 | 0 | 0 | $304000 | 0 | 0 | $410000 | $446000 |
| Activos Corrientes | $12.7M | $8.5M | $8.6M | $23.0M | $9.2M | $39.1M | $25.5M | $10.7M | $11.8M | $15.3M |
| Inmovilizado Material | $688000 | $822000 | $614000 | $3.7M | $6.5M | $8.4M | $10.9M | $5.4M | $2.8M | $2.8M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | $9.2M | $18.7M | 0 | 0 | 0 | 0 |
| Activos Intangibles | $988000 | $746000 | 0 | 0 | $15.0M | $61.7M | $61.6M | $56.6M | $14.6M | 0 |
| Activos Totales | $14.4M | $10.2M | $9.5M | $39.9M | $55.4M | $159.6M | $100.1M | $74.9M | $35.1M | $25.8M |
| Cuentas por Pagar | $422000 | $175000 | $166000 | $469000 | $432000 | $1.8M | $1.3M | $953000 | $2.3M | $2.5M |
| Deuda a Corto | 0 | $1.1M | $1.2M | $1.4M | $2.4M | $1.3M | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $4.3M | $4.5M | $5.6M | $4.4M | $9.0M | $14.1M | $12.1M | $7.2M | $7.3M | $12.1M |
| Deuda a Largo | 0 | $1.1M | $347000 | $1.9M | $1.5M | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $4.6M | $5.8M | $6.1M | $9.0M | $21.9M | $94.3M | $60.5M | $54.4M | $47.4M | $57.2M |
| Reservas | -$35.3M | -$54.7M | -$71.3M | -$93.7M | -$123.7M | -$187.8M | -$260.7M | -$289.9M | -$350.5M | -$400.8M |
| Patrimonio Neto | $9.9M | $4.4M | $3.4M | $30.8M | $33.5M | $65.2M | $39.6M | $20.5M | -$12.3M | -$31.5M |
| Deuda Total | $512000 | $2.5M | $1.7M | $6.2M | $8.6M | $5.7M | $3.5M | $2.9M | $3.7M | $3.5M |
| Deuda Neta | -$11.9M | -$5.9M | -$6.7M | -$16.3M | $814000 | -$28.2M | -$16.9M | -$6.6M | -$5.0M | -$8.1M |
| Capital Circulante | $8.4M | $4.1M | $3.1M | $18.5M | $230000 | $25.0M | $13.4M | $3.5M | $4.5M | $3.2M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $18.7M | $11.6M | $28.2M | $17.8M |
| Activos Totales | $43.9M | $25.8M | $40.4M | $29.4M |
| Pasivos Totales | $53.1M | $57.2M | $51.1M | $50.7M |
| Patrimonio Neto | -$9.2M | -$31.5M | -$10.7M | -$21.3M |
| Deuda Total | $3.1M | $3.5M | $3.1M | $2.6M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$11.2M | -$19.4M | -$15.8M | -$22.4M | -$29.9M | -$64.1M | -$72.9M | -$27.8M | -$60.7M | -$50.2M |
| Amortizaciones | $387000 | $580000 | $559000 | $351000 | $394000 | $4.2M | $5.2M | $1.7M | $1.6M | $2.2M |
| Compensación en Acciones | $922000 | $1.6M | $1.5M | $3.0M | $5.1M | $6.8M | $10.0M | $6.6M | $1.9M | $2.2M |
| Cambio en Capital Circulante | $2.3M | -$686000 | $993000 | -$1.6M | $2.0M | $149000 | -$1.9M | -$4.0M | -$1.3M | $2.7M |
| Flujo de Caja Operativo | -$7.5M | -$13.4M | -$11.6M | -$19.7M | -$26.0M | -$35.9M | -$45.6M | -$23.3M | -$20.7M | -$22.2M |
| Inversiones (CapEx) | -$106000 | -$91000 | -$31000 | -$918000 | -$1.2M | -$2.2M | -$4.3M | -$281000 | -$516000 | -$3.2M |
| Adquisiciones | 0 | 0 | 0 | -$11.2M | -$10.5M | -$11.7M | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | -$14000 | -$239000 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | -$96000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$7.6M | -$13.5M | -$11.7M | -$20.6M | -$27.2M | -$38.2M | -$49.9M | -$23.6M | -$21.2M | -$25.4M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$4.5M | -$5.5M | -$7.6M | -$9.3M |
| Inversiones (CapEx) | -$1.1M | -$1.5M | -$613000 | -$779000 |
| Flujo de Caja Libre | -$5.6M | -$7.0M | -$8.3M | -$10.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $521000 | $721000 | $615000 | $661000 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | | +80.8% | -56.4% | +56.9% | +25.1% | +115.6% |
| Crecimiento Beneficio Neto (anual) | | -73.5% | +18.7% | -41.7% | -34.0% | -114.1% | -13.7% | +61.9% | -118.4% | +17.2% |
| Crecimiento BPA (anual) | | -52.4% | +35.2% | -4.7% | -4.9% | -57.5% | -38.9% | +81.2% | -24.3% | +64.6% |
| Cambio en Acciones (anual) | | +13.8% | +25.4% | +35.5% | +27.6% | +35.8% | +24.6% | +38.1% | +70.8% | +133.2% |
| Crecimiento FCF (anual) | | -76.7% | +13.3% | -76.7% | -31.9% | -40.4% | -30.7% | +52.7% | +10.1% | -19.5% |
| Margen Bruto | | | | | -52.5% | 64.6% | -1.9% | 27.5% | 39.3% | 4.7% |
| Margen Operativo | | | | | -2443.3% | -2444.3% | -1878.6% | -1672.4% | -3245.1% | -754.1% |
| Margen EBITDA | | | | | -2511.5% | -2204.6% | -1389.2% | -1538.5% | -3137.4% | -1181.7% |
| Margen Neto | | | | | -2461.5% | -2916.2% | -7609.8% | -1848.4% | -3225.0% | -1238.5% |
| Margen FCF | | | | | -2237.4% | -1737.4% | -5209.6% | -1570.6% | -1128.6% | -625.6% |
| Tasa Impositiva Efectiva | -0.0% | -0.0% | -0.0% | -0.0% | 4.0% | 17.5% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-5.75 | $-8.93 | $-6.17 | $-8.04 | $-8.31 | $-8.59 | $-9.01 | $-3.09 | $-1.62 | $-0.83 |
| Dividendo por Acción | $0.00 | $0.00 | $0.05 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.3M | $1.5M | $1.9M | $2.6M | $3.3M | $4.4M | $5.5M | $7.7M | $13.1M | $30.5M |
Qué mirar en Salud / Farma
El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.
- I+D / Ingresos — Indica inversión en pipeline futuro. Farma seria reinvierte 15-20%
- Crecimiento EPS 5y — Tras caducidad de patentes, ¿siguen creciendo?
- Margen bruto — Farma de marca >70%. Genéricos mucho más bajo — define el tipo de negocio
- FCF / Net Income — Calidad del beneficio — farma grande debería convertir >90%
- ROIC — Capital reinvertido con eficiencia — clave en farma por ciclos de I+D largos
- Deuda neta / EBITDA — Adquisiciones de farma generan mucha deuda — ojo al post-M&A
- P/E vs historial 10y propio — La mejor comparación es con su propia historia, no con competidores
Rentabilidad
| Rentabilidad sobre capital | 271.76% |
| Rentabilidad sobre capital invertido | -204.78% |
| Rentabilidad sobre activos | -167.64% |
| Margen bruto | 11.17% |
| Margen operativo | -2558.74% |
| Margen neto | -2955.63% |
Salud financiera
| Deuda / Patrimonio | -0.12 |
| Ratio corriente | 2.00 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -16.75 | -7.25 | -3.32 | -5.17 | -5.23 | -3.01 | -0.32 | -0.67 | -0.51 | -4.55 |
| P/VC | 18.96 | 31.89 | 15.26 | 3.74 | 4.67 | 2.96 | 0.90 | 0.93 | -2.53 | -7.26 |
| P/V | 0.00 | 0.00 | 0.00 | 0.00 | 128.69 | 87.79 | 37.13 | 12.73 | 16.54 | 56.37 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | 0.0% | -52.5% | 64.6% | -1.9% | 27.5% | 39.3% | 4.7% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | 0.0% | -2443.3% | -2444.3% | -1878.6% | -1672.4% | -3245.1% | -754.1% |
| Margen Neto | 0.0% | 0.0% | 0.0% | 0.0% | -2461.5% | -2916.2% | -7609.8% | -1848.4% | -3225.0% | -1238.5% |